Literature DB >> 28751286

Troponin elevation in other conditions than acute coronary syndromes.

Wafa Masri1, Edouard Le Guillou1, Eya Hamdi1, Khaldoun Ghazal1, Elise Lebigot1, Claudine Cosson1, Françoise Blonde Cynober1, Patrice Therond1.   

Abstract

Troponin is a specific cardiac infarction isoform (TnIc, TnTc) and its determination is used for the diagnosis of myocardial infarction even with normal Electrocardiography. The increase of cardiac troponins occurs in a variety of clinical situations without an acute coronary syndrome (ACS), cardiologists and emergency physicians are often confronted with positive troponins that are difficult to interpret. Few data exist about the occurrence, the clinical characteristics and the predictive value in case of absence of ACS. The objective of this study is to present the main extracardiac causes responsible of the increase of TnIc. We present some clinical cases that illustrate this diagnostic problem. A troponin elevation is observed in myopericarditis, renal failure, heart failure, pulmonary embolism, septic shock, rhabdomyolysis, stroke and others where there is a myocardial damage unrelated to coronary occlusion. Many cases of false positives, which raise the possibility of analytical interferences, must be identified.

Entities:  

Keywords:  acute coronary syndrome; extra coronary pathologies; troponin

Mesh:

Substances:

Year:  2017        PMID: 28751286     DOI: 10.1684/abc.2017.1262

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  2 in total

1.  Multiple admissions to the coronary care unit due to falsely elevated cardiac troponin.

Authors:  Mohamed Ayan; Zaid Gheith; Aneesha Ananthula; Mohsin Salih; Srikanth Vallurupalli; Jawahar L Mehta
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-03-15

2.  Effects of perilipin-5 on lipid metabolism and high-sensitivity cardiac troponin I.

Authors:  İbrahim Ethem; Ceyhan Hacıoğlu
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-08       Impact factor: 1.712

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.